These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 3630645)

  • 1. CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis?
    Aarli JA; Gilhus NE; Hofstad H
    Acta Neurol Scand; 1987 Jul; 76(1):55-7. PubMed ID: 3630645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis].
    Sund KK; Skeie GO; Gilhus NE; Aarli JA; Varhaug JE
    Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4212-4. PubMed ID: 9441462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle antibodies in patients with a thymic tumour but without myasthenia gravis.
    Gilhus NE; Aarli JA; Janzen RW; Otto HF; Fasske E; Matre R
    J Neuroimmunol; 1985 May; 8(2-3):69-78. PubMed ID: 3998123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis of thymoma in myasthenia gravis.
    Aarli JA
    Ital J Neurol Sci; 1983 Dec; 4(4):393-7. PubMed ID: 6370907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reactivity of the antistriational antibodies associated with thymoma and myasthenia gravis.
    Peers J; McDonald BL; Dawkins RL
    Clin Exp Immunol; 1977 Jan; 27(1):66-73. PubMed ID: 321160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholine receptor antibody measurements in acquired myasthenia gravis. Diagnostic sensitivity and predictive value for thymoma.
    Husain AM; Massey JM; Howard JF; Sanders DB
    Ann N Y Acad Sci; 1998 May; 841():471-4. PubMed ID: 9668277
    [No Abstract]   [Full Text] [Related]  

  • 7. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenia gravis muscle antibodies examined by ELISA: IgG and IgM antibodies characterize different patient subgroups.
    Hofstad H; Ulvestad E; Gilhus NE; Matre R; Aarli JA
    Acta Neurol Scand; 1992 Apr; 85(4):233-8. PubMed ID: 1585794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to skeletal muscle in myasthenia gravis. Part 1. Diagnostic value for the detection of thymoma.
    Kuks JB; Limburg PC; Horst G; Dijksterhuis J; Oosterhuis HJ
    J Neurol Sci; 1993 Nov; 119(2):183-8. PubMed ID: 8277333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological detection of thymoma in myasthenia gravis.
    Aarli JA; Thunold S
    Eur Neurol; 1981; 20(5):380-7. PubMed ID: 7285988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.
    Ohta M; Itoh M; Hara H; Itoh N; Nishitani H; Hayashi K; Ohta K
    Clin Chim Acta; 1991 Sep; 201(3):201-5. PubMed ID: 1756593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoma-specific antibodies in sera from patients with myasthenia gravis demonstrated by indirect haemagglutination.
    Aarli JA; Lefvert AK; Tönder O
    J Neuroimmunol; 1981 Dec; 1(4):421-7. PubMed ID: 7346525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appearance of thymoma 15 years after extended thymectomy for myasthenia gravis without thymoma.
    Hirabayashi H; Ohta M; Okumura M; Matsuda H
    Eur J Cardiothorac Surg; 2002 Sep; 22(3):479-81. PubMed ID: 12204753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis with thymoma is not associated with an increased incidence of non-muscle autoimmune disorders.
    Aarli JA; Gilhus NE; Matre R
    Autoimmunity; 1992; 11(3):159-62. PubMed ID: 1571478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-LRP4 Antibody-associated Myasthenia Gravis with a Rare Complication of Thymoma Successfully Treated by Thymectomy.
    Aoki S; Nagashima K; Furuta M; Makioka K; Fujita Y; Saito K; Kashima T; Nakajima N; Ikota H; Higuchi O; Ikeda Y
    Intern Med; 2020 May; 59(9):1219-1222. PubMed ID: 32051380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
    Reinhardt C; Melms A
    Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis developing after discovery of thymoma.
    Wakata N; Fukuya H; Niizuma M; Ishida T; Kinoshita M
    Clin Neurol Neurosurg; 1992; 94(4):303-6. PubMed ID: 1335857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
    Smith CI; Aarli JA; Hammarström L; Persson MA
    Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis-associated antibodies in asymptomatic thymoma.
    Moore HJ; Woods EL
    J Thorac Cardiovasc Surg; 1985 Feb; 89(2):308-10. PubMed ID: 3968916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired generalised neuromyotonia, cutaneous lupus erythematosus and alopecia areata in a patient with myasthenia gravis.
    O'Sullivan SS; Mullins GM; Neligan A; McNamara B; Galvin RJ
    Clin Neurol Neurosurg; 2007 May; 109(4):374-5. PubMed ID: 17239529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.